1. Clinicopathological and Prognostic Significance of PRMT5 in Cancers: A System Review and Meta-Analysis. (1st October 2021) Authors: Liang, Zhenzhen; Liu, Lianchang; Wen, Chaowei; Jiang, Heya; Ye, Tianxia; Ma, Shumei; Liu, Xiaodong Journal: Cancer control Issue: Volume 28(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of methylglyoxal and glyoxalase I inhibition on breast cancer cells proliferation, invasion, and apoptosis through modulation of MAPKs, MMP9, and Bcl-2. Issue 2 (1st February 2016) Authors: Guo, Yi; Zhang, Yuning; Yang, Xunjun; Lu, Panpan; Yan, Xijuan; Xiao, Fanglan; Zhou, Huaibin; Wen, Chaowei; Shi, Mengru; Lu, Jianxin; Meng, Qing H. Journal: Cancer biology & therapy Issue: Volume 17:Issue 2(2016) Page Start: 169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Increased levels of circulating oxidized mitochondrial DNA contribute to chronic inflammation in metabolic syndrome, and MitoQ-based antioxidant therapy alleviates this DNA-induced inflammation. (15th January 2023) Authors: Ye, Wei; Wen, Chaowei; Zeng, Aibing; Hu, Xingzhong Journal: Molecular and cellular endocrinology Issue: Volume 560(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Mutations in FASTKD2 are associated with mitochondrial disease with multi‐OXPHOS deficiency. Issue 5 (30th January 2020) Authors: Wei, Xiujuan; Du, Miaomiao; Li, Dongxiao; Wen, Shumeng; Xie, Jie; Li, Yuanyuan; Chen, Aolong; Zhang, Kun; Xu, Pu; Jia, Manli; Wen, Chaowei; Zhou, Huaibin; Lyu, Jianxin; Yang, Yanling; Fang, Hezhi Journal: Human mutation Issue: Volume 41:Issue 5(2020) Page Start: 961 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗